Literature DB >> 24969580

Neurocognitive functioning in children and adolescents at the time of type 1 diabetes diagnosis: associations with glycemic control 1 year after diagnosis.

David D Schwartz1, Marni E Axelrad2, Barbara J Anderson2.   

Abstract

OBJECTIVE: To determine whether impairments in neurocognitive functioning are detectable at type 1 diabetes diagnosis and associated with subsequent glycemic control. RESEARCH DESIGN AND METHODS: Children/adolescents (N = 147) aged 5-18 years completed neuropsychological testing during their inpatient hospitalization for new-onset type 1 diabetes. Test scores were compared with normative data using one-sample Student t tests. Children with onset before 8 years of age were compared with children aged 9-18 years using ANOVA, and associations between neurocognitive performance at diagnosis and glycemic control 1 year postdiagnosis were examined using regression analyses.
RESULTS: Children with type 1 diabetes performed significantly below expectations on most neurocognitive measures (P values <0.0001), with large decrements from the normative mean evident in psychomotor speed (>1 SD), visuomotor integration (0.7 SD), and phonemic fluency (0.8 SD). High incidence of impairment (scores less than second percentile) was evident on all tasks except digit span. Dominant-hand psychomotor speed was significantly associated with poor glycemic control (A1C ≥9.5% [80 mmol/mol]; P = 0.032) 1 year postdiagnosis, controlling for race/ethnicity, sex, and reading ability. Impaired psychomotor speed was associated with a 0.77% increase in mean A1C (8.4 mmol/mol).
CONCLUSIONS: Deficits were evident in neurocognitive functioning within days of diabetes diagnosis that were associated with diabetes outcomes over 1 year postdiagnosis. Impairment was most apparent in psychomotor speed, consistent with research implicating damage to posterior white matter tracts and associated gray matter regions in type 1 diabetes. Psychomotor impairment may be an early marker for a broader neurobehavioral vulnerability that has implications for long-term diabetes management.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24969580     DOI: 10.2337/dc14-0103

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  9 in total

Review 1.  Neurocognitive outcomes in pediatric diabetes: a developmental perspective.

Authors:  David D Schwartz; Rachel Wasserman; Priscilla W Powell; Marni E Axelrad
Journal:  Curr Diab Rep       Date:  2014-10       Impact factor: 4.810

2.  Regional Gray Matter Volumes as Related to Psychomotor Slowing in Adults with Type 1 Diabetes.

Authors:  Karen A Nunley; Christopher M Ryan; Howard J Aizenstein; J Richard Jennings; Rebecca L MacCloud; Trevor J Orchard; Caterina Rosano
Journal:  Psychosom Med       Date:  2017-06       Impact factor: 4.312

3.  Clinical presentation and memory function in youth with type 1 diabetes.

Authors:  Katherine Semenkovich; Allison Bischoff; Tasha Doty; Suzanne Nelson; Alejandro F Siller; Tamara Hershey; Ana Maria Arbeláez
Journal:  Pediatr Diabetes       Date:  2015-09-17       Impact factor: 4.866

Review 4.  Prediabetes and associated disorders.

Authors:  Martin Buysschaert; José Luís Medina; Michael Bergman; Avni Shah; Jaqueline Lonier
Journal:  Endocrine       Date:  2014-10-08       Impact factor: 3.633

5.  Altered gray matter volume in children with newly diagnosed type 1 diabetes mellitus.

Authors:  Kun Liu; Haiyan Su; Jiawen Song; Shihan Cui; Xiaoyan Huang; Yongjin Zhou; Xiaozheng Liu; Xiaoou Shan; Zhihan Yan; Xinjian Ye
Journal:  Pediatr Res       Date:  2022-08-02       Impact factor: 3.953

6.  Screening of Neurocognitive and Executive Functioning in Children, Adolescents, and Young Adults With Type 1 Diabetes.

Authors:  Rachel M Wasserman; Barbara J Anderson; David D Schwartz
Journal:  Diabetes Spectr       Date:  2016-11

7.  Glycemic extremes are related to cognitive dysfunction in children with type 1 diabetes: A meta-analysis.

Authors:  Jing He; Andrew G Ryder; Shichen Li; Wanting Liu; Xiongzhao Zhu
Journal:  J Diabetes Investig       Date:  2018-04-17       Impact factor: 4.232

8.  Abnormal Functional Connectivity Density in New-Onset Type 1 Diabetes Mellitus Children: A Resting-State Functional Magnetic Resonance Imaging Study.

Authors:  Kun Liu; Jiawen Song; Jiahui Jin; Xiaoyan Huang; Xinjian Ye; Shihan Cui; Yongjin Zhou; Xiaozheng Liu; Wei Chen; Zhihan Yan; Xiaoou Shan; Yuchuan Fu
Journal:  Front Psychiatry       Date:  2020-04-17       Impact factor: 4.157

Review 9.  Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report.

Authors:  Diane K Wherrett; Jane L Chiang; Alan M Delamater; Linda A DiMeglio; Stephen E Gitelman; Peter A Gottlieb; Kevan C Herold; Daniel J Lovell; Trevor J Orchard; Christopher M Ryan; Desmond A Schatz; David S Wendler; Carla J Greenbaum
Journal:  Diabetes Care       Date:  2015-10       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.